MTOR and neoplasm: We speculate that CCND1 gene amplification activates metabolism signaling pathways, such as the enhanced oxidative metabolism in cancer cells promotes activation of PI3K-Akt-mTOR signal axis, and then constructs an immune barrier of tumor microenvironment, resulting in resistance to ICIs therapies.